technology, doctors say.
Leila Richards, 16 months and 11 months was not introduced with the cells of the immune
system and genetically modified to Great Ormond Street Hospital in London.
Immune cells designed to attack cancer cells, after previous attempts to treat children who
use traditional methods.
A year ago, doctors describe the reactions of children to treatment as a "miracle" and
almost shocking success of the first in the world for cancer connection.
The experiment raises the possibility of using donors from low-cost off-the-shelf cell
therapy can be dripped into a vein of the patient at the time.
Treatment using the technique of t cells, known as fairly new t car and not sold
commercially. But also a great success for blood cancer.
The case received a lot of attention for its share of criticism. Because both receive
chemotherapy, critics said that the researchers were able to prove that a car that cured them.
Technology review, Stephan Grupp, Director of immunotherapy in Pediatric Oncology
Hospital of Philadelphia, said: "there are signs of success, but there is no evidence.
It would be great if it works, but just doesn't show yet. '
However, Wasim Qasim as a teacher, a doctor and specialist in the field of gene therapy,
which causes test, it was reported that two children remain in remission-18 1 month after treatment and a year after treatment.
In the past year, Layla Richards was the first child to undergo therapy, after she was
diagnosed with acute lymphoblastic leukemia (all).
2000 children diagnosed each year. Although almost all remission, experts say parents Laila
is that they have never seen a more aggressive case.
Layla's mother, Lisa Foley, said at the time: "we do not want to receive palliative care
[end of life] and therefore call on doctors to try anything for our daughter, though he has
never tried before.
"We consider ourselves lucky that we're in the right place at the right time to pick up a
bottle of cells."
' I hope that Layla will keep well and many other kids can help with this new treatment. '
His father, Ashleigh Richards, added: "shudders to think that treatment is never used in
the human body, but even with these risks, there is no doubt that we wanted to try the treatment.
"You hurt and so much pain, that we had to do something.
Immunotherapy, he brought a great investment, but there are a lot of problems, try to sell it.
In other versions of out-of-the-road-shelf approach, blood will be collected from a donor
and then changed to "hundreds of doses that can be stored frozen. The estimated cost for
the dose is around $4000.
Although expensive, was genetically the same methods that carry cells from individual
patients, modify them and attack the cancer. Treatment costs about $50000 per dose.
Document that details about treatments, which have been published, with great excitement,
but also warn of "critical" alert on the effectiveness of new treatments.
Risks, including potentially fatal disease from host concession in which cells from the
donor starts to attack the recipient.
0 comments: